<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53532">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01760031</url>
  </required_header>
  <id_info>
    <org_study_id>RenPro1L</org_study_id>
    <nct_id>NCT01760031</nct_id>
  </id_info>
  <brief_title>Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy</brief_title>
  <acronym>RenProLong</acronym>
  <official_title>Remote Preconditioning for Contrast-Induced Acute Kidney Injury: Long-Term Follow up (RenPro Longterm)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Remote ischemic preconditioning reduces the incidence of contrast-induced acute kidney
      injury in patients undergoing elective coronary angiography. This study was designed to
      acquire long-term data of initially randomized patients in the RenPro Trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data of the RenPro Trial has been already published. In the present study data of longterm
      follow up are collected.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>MACCE</measure>
    <time_frame>1 Year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Major Adverse Cardiac and Cerebrovascular Events (Combined primary endpoint):
All-cause mortality, cardiovascular mortality, rehospitalization, stroke, myocardial infarction, hemodialysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal function</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>changes of serum creatinine, eGFR, NGAL and cystatin C compared to baseline in both groups.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">81</enrollment>
  <condition>Impaired Renal Function</condition>
  <arm_group>
    <arm_group_label>Subjects with impaired renal function</arm_group_label>
    <description>Subjects with baseline impaired renal function undergoing cardiac catheterization with contrast-medium exposure</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ischemic preconditioning</intervention_name>
    <description>Subjects received ischemic preconditioning previous to cardiac catheterization</description>
    <arm_group_label>Subjects with impaired renal function</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients refered for elective cardiac catherization to the university hospital of Cologne.
        All patients who participated to the RenPro trial (www.germanctr.de; DRKS-ID DRKS00000666)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        All patients who participated to the RenPro trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fikret Er, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Cologne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, Caglayan E, Kubacki T, Benzing T, Erdmann E, Burst V, Gassanov N. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation. 2012 Jul 17;126(3):296-303. doi: 10.1161/CIRCULATIONAHA.112.096370. Epub 2012 Jun 26.</citation>
    <PMID>22735306</PMID>
  </results_reference>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 28, 2012</lastchanged_date>
  <firstreceived_date>December 28, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Dr. Fikret Er</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>preconditioning</keyword>
  <keyword>contrast-induced acute kidney injury</keyword>
  <keyword>renal faliure</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
